Novartis' former weight loss med Sanorex at center of New Jersey pharma chief's guilty plea

After being charged with deceiving the FDA last fall, purported New Jersey pharma CEO Alain Bouaziz had his day in court. Now, the 69-year-old French citizen faces up to five years in prison—plus a maximum fine of $250,000—over a plot to get his hands on Novartis’ former weight loss med Sanorex.